Company Legal Name
Latest Valuation
Founded Year
Headquarters
Synchron, Inc. develops endovascular brain-computer interfaces that enable paralyzed patients to control digital devices through thought alone. Founded in 2012 and headquartered in Brooklyn, the company has pioneered a minimally invasive approach to brain-computer interface technology, utilizing blood vessels to access the brain rather than requiring open surgery. This endovascular method differentiates Synchron from competitors by reducing surgical risks and potentially accelerating patient adoption. The company's flagship technology translates neural signals into digital commands, allowing patients with severe paralysis to operate computers, smartphones, and other devices directly through mental intention. Synchron has achieved significant regulatory milestones, becoming the first company to receive FDA approval for a permanently implanted brain-computer interface in human patients. The technology addresses a substantial unmet medical need for individuals with conditions such as ALS, stroke, and spinal cord injuries. Synchron continues to advance clinical development while expanding its platform capabilities to serve the growing market for neural interface solutions.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
